LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | PHA-665752 | 3.33 | uM | LJP5 | 1 | F14 | 72 | hr | 1235 | 4302 | 4474 | 0.9614 | 0.9580 |
MDA-MB-231 | PHA-665752 | 3.33 | uM | LJP5 | 2 | F14 | 72 | hr | 1235 | 4359 | 4578 | 0.9520 | 0.9487 |
MDA-MB-231 | PHA-665752 | 3.33 | uM | LJP5 | 3 | F14 | 72 | hr | 1235 | 4370 | 4929 | 0.8865 | 0.8829 |
MDA-MB-231 | PHA-665752 | 10 | uM | LJP5 | 1 | F13 | 72 | hr | 1235 | 133 | 4474 | 0.0297 | -0.6991 |
MDA-MB-231 | PHA-665752 | 10 | uM | LJP5 | 2 | F13 | 72 | hr | 1235 | 130 | 4578 | 0.0284 | -0.6964 |
MDA-MB-231 | PHA-665752 | 10 | uM | LJP5 | 3 | F13 | 72 | hr | 1235 | 131 | 4929 | 0.0266 | -0.6752 |
MDA-MB-231 | PI103 | 0.04 | uM | LJP6 | 1 | I18 | 72 | hr | 1235 | 3102 | 4355 | 0.7121 | 0.6592 |
MDA-MB-231 | PI103 | 0.04 | uM | LJP6 | 2 | I18 | 72 | hr | 1235 | 3274 | 4277 | 0.7654 | 0.7227 |
MDA-MB-231 | PI103 | 0.04 | uM | LJP6 | 3 | I18 | 72 | hr | 1235 | 3292 | 4583 | 0.7183 | 0.6789 |
MDA-MB-231 | PI103 | 0.12 | uM | LJP6 | 1 | I17 | 72 | hr | 1235 | 2594 | 4355 | 0.5955 | 0.5037 |
MDA-MB-231 | PI103 | 0.12 | uM | LJP6 | 2 | I17 | 72 | hr | 1235 | 2710 | 4277 | 0.6336 | 0.5501 |
MDA-MB-231 | PI103 | 0.12 | uM | LJP6 | 3 | I17 | 72 | hr | 1235 | 2701 | 4583 | 0.5893 | 0.5121 |
MDA-MB-231 | PI103 | 0.37 | uM | LJP6 | 1 | I16 | 72 | hr | 1235 | 2016 | 4355 | 0.4628 | 0.3090 |
MDA-MB-231 | PI103 | 0.37 | uM | LJP6 | 2 | I16 | 72 | hr | 1235 | 2228 | 4277 | 0.5209 | 0.3896 |
MDA-MB-231 | PI103 | 0.37 | uM | LJP6 | 3 | I16 | 72 | hr | 1235 | 608 | 4583 | 0.1327 | -0.3129 |
MDA-MB-231 | PI103 | 1.11 | uM | LJP6 | 1 | I15 | 72 | hr | 1235 | 1689 | 4355 | 0.3878 | 0.1875 |
MDA-MB-231 | PI103 | 1.11 | uM | LJP6 | 2 | I15 | 72 | hr | 1235 | 2008 | 4277 | 0.4695 | 0.3112 |
MDA-MB-231 | PI103 | 1.11 | uM | LJP6 | 3 | I15 | 72 | hr | 1235 | 1809 | 4583 | 0.3947 | 0.2232 |
MDA-MB-231 | PI103 | 3.33 | uM | LJP6 | 1 | I14 | 72 | hr | 1235 | 1471 | 4355 | 0.3377 | 0.1005 |
MDA-MB-231 | PI103 | 3.33 | uM | LJP6 | 2 | I14 | 72 | hr | 1235 | 1753 | 4277 | 0.4098 | 0.2155 |
MDA-MB-231 | PI103 | 3.33 | uM | LJP6 | 3 | I14 | 72 | hr | 1235 | 1612 | 4583 | 0.3517 | 0.1508 |
MDA-MB-231 | PI103 | 10 | uM | LJP6 | 1 | I13 | 72 | hr | 1235 | 1065 | 4355 | 0.2445 | -0.0786 |
MDA-MB-231 | PI103 | 10 | uM | LJP6 | 2 | I13 | 72 | hr | 1235 | 1154 | 4277 | 0.2698 | -0.0376 |
MDA-MB-231 | PI103 | 10 | uM | LJP6 | 3 | I13 | 72 | hr | 1235 | 1198 | 4583 | 0.2614 | -0.0164 |
MDA-MB-231 | Dovitinib | 0.04 | uM | LJP5 | 1 | E24 | 72 | hr | 1235 | 4345 | 4474 | 0.9710 | 0.9686 |